| | Country | Authors | Year | Number of cases | Treatment | Outcome |
| | Greece | Benecos et al. | 1998 | 1 | IVIG, TMP/SMX, streptomycin | Good | | Tsirka et al. | 2002 | 1 | IVIG, gentamycin, doxycycline, rifampicin | Good | | Tsolia et al. | 2002 | 2 | TMP/SMX, rifampicin | Good |
| | Turkey | Sevinc et al. | 2000 | 1 | Corticosteroids, TMP/SMX, rifampicin, ciprofloxacin | Good | | Yalaz et al. | 2004 | 1 | Doxycycline, rifampicin | Good | | Ulug et al. | 2011 | 1 | TMP/SMX, rifampicin | Good | | Akbayram et al. | 2011 | 5 | Doxycycline and rifampicin (>8 years) or TMP/SMX and rifampicin (<8 years) | Good | | Citak et al. | 2010 | 5 | IVIG, TMP/SMX, rifampicin | Good | | Aypak et al. | 2016 | 11 | Doxycycline and rifampicin (>8 years) or TMP/SMX and rifampicin (<8 years) | Good | | Karaman et al. | 2016 | 15 | Doxycycline and rifampicin (>8 years) or TMP/SMX and rifampicin (<8 years) | Good |
| | Saudi Arabia | Benjamin and Annobil | 1992 | 4 | Rifampicin, TMP/SMX, doxycycline, streptomycin | Good | | Al-Eissa and Al-Nasser | 1993 | 5 | Rifampicin, TMP/SMX, doxycycline, streptomycin | Good | | Benjamin | 1995 | 2 | Rifampicin, TMP/SMX, doxycycline | Good |
| | Lebanon | Farah et al. | 2010 | 1 | IVIG, TMP/SMX, gentamicin | Good |
| | Israel | Marom et al. | 2000 | 1 | Rifampicin, TMP/SMX | Good |
| | Iran | Kamali Aghdam et al. | 2016 | 1 | IVIG, rifampicin, TMP/SMX | Good |
|
|
